Grail to present new NHS-Galleri, PATHFINDER 2 data on Galleri cancer test at EDCC, ESMO 2026

Bitget2026/10/05 20:01

Grail flagged new data from the NHS-Galleri trial and PATHFINDER 2 for release at EDCC on Oct. 6-8, 2026. Additional results are scheduled for ESMO Congress 2026 on Oct. 23-27, 2026. Readouts are set to support the Galleri multi-cancer test’s performance across diverse populations, including racial and ethnic groups. Planned presentations also address real-world diagnostic workups, including safety, efficiency, earlier detection potential, and fewer emergency cancer diagnoses. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610051601PR_NEWS_USPR_____LA64117) on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

华尔街见闻•2026/10/11 01:57

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

BeInCrypto•2026/10/10 22:48

The number of stablecoin holders on the Solana chain has surpassed 14 million.

AiCoin•2026/10/10 21:35

Cathie Wood’s ARK Sells Bitcoin ETF, SpaceX and Robinhood Shares in Portfolio Shift

CoinEdition•2026/10/10 17:39